semaj83/ctmatch_classification huggingface dataset:
Patient description: The patients is a 25-year-old G1 P1 pregnant woman who is 24W3D gestational old who developed a sudden unset of fever and chills, accompany with nausea and vomiting. She also complains of dysuria, urgency and frequency. She also reports some severe pain in the flank. Her vital signs are: T = 39.7ºC, P = 117, R = 20, and BP = 113/74 mm Hg. Physical examination reveals tenderness on palpation of both costovertebral angles. She has no history of recurrent UTI prior to her pregnancy or any other underlying disease. The urine culture showed Gram-negative rod-shaped bacterial cells, leukocytes, and leukocyte casts. The blood culture is negative. A CBC shows Hb 12.9 g/dL, Hct 39%, MCV 76 fL, WBC count 14,120/µL.

Clinical trial eligibility criteria: eligible ages (years): 18.0-999.0,  Acute Pyelonephritis Without Severity Symptoms Due to ESBL-producing E.Coli Acute pyelonephritis without severity symptoms with a positive urine culture for ESBL-producing E. coli (cefoxitin-sensitive); antibiotic treatment should have been prescribed before for the empirical treatment of pyelonephritis, providing it is not active in vitro against ESBL-producing E. coli strain Presenting at least a functional sign of urinary infection (dysuria, cloudy urine, pain on urination, pelvic or lumbar pain) Temperature >38 ° or < 36° during the infectious episode Imaging of the urinary ways realized within (echography) 72 hours preceding the inclusion  Pregnant women β-lactam allergy antimicrobial therapy active in vitro against ESBL-producing E.coli pyelonephritis instituted prior to enrolment life expectancy <30 days creatinine clearance <30 ml/min patient under guardianship or without healthcare coverage Sign of sepsis severe or septic shock Major cognitive confusions Patients having refused to give her consent form in writing Not membership in a national insurance scheme or in the Universal Health Coverage (CMU)
Patient description: The patients is a 25-year-old G1 P1 pregnant woman who is 24W3D gestational old who developed a sudden unset of fever and chills, accompany with nausea and vomiting. She also complains of dysuria, urgency and frequency. She also reports some severe pain in the flank. Her vital signs are: T = 39.7ºC, P = 117, R = 20, and BP = 113/74 mm Hg. Physical examination reveals tenderness on palpation of both costovertebral angles. She has no history of recurrent UTI prior to her pregnancy or any other underlying disease. The urine culture showed Gram-negative rod-shaped bacterial cells, leukocytes, and leukocyte casts. The blood culture is negative. A CBC shows Hb 12.9 g/dL, Hct 39%, MCV 76 fL, WBC count 14,120/µL.

Clinical trial eligibility criteria: eligible ages (years): 18.0-45.0,  Preeclampsia Hypertension Proteinuria Pregnancy Cases: 1. Pregnancy week 28-36 (exclusion of patients with previously severe preeclampsia). 2. Singleton pregnancy 3. Preeclampsia hypertension: repetitive high blood pressures (> 140/80 mm Hg) measured in the consultation and proteinuria (dip test, albumin). 4. Pregnant with microalbuminuria and proteinuria, but without hypertension (and therefore do not meet the diagnostic for preeclampsia) can also be included. Proteinuria is the most important factor. It is still possible to test our hypothesis with possible comorbidity such as diabetes, SLE(systemic lupus erythematosus), rheumatoid arthritis and therefore not a reason for exclusion  Hypertension in pregnancy without proteinuria. 2. Pregestational nephropathy by other unknown reasons. 3. Early severe preeclampsia. 4. Organic or systemic disease of clinical relevance, such as malignancy. Pregnant controls- 1. pregnancy week 28-36 2. Singleton pregnancy 3. Uncomplicated pregnancy Hypertension 2. Any kind of nephropathy 3. Organic or systemic disease of clinical relevance, such as malignancy. Non-pregnant controls: 1. woman, not pregnant 2. Matched by age and BMI Hypertension 2. Any kind of nephropathy 3. Organic or systemic disease of clinical relevance, such as malignancy
Patient description: The patients is a 25-year-old G1 P1 pregnant woman who is 24W3D gestational old who developed a sudden unset of fever and chills, accompany with nausea and vomiting. She also complains of dysuria, urgency and frequency. She also reports some severe pain in the flank. Her vital signs are: T = 39.7ºC, P = 117, R = 20, and BP = 113/74 mm Hg. Physical examination reveals tenderness on palpation of both costovertebral angles. She has no history of recurrent UTI prior to her pregnancy or any other underlying disease. The urine culture showed Gram-negative rod-shaped bacterial cells, leukocytes, and leukocyte casts. The blood culture is negative. A CBC shows Hb 12.9 g/dL, Hct 39%, MCV 76 fL, WBC count 14,120/µL.

Clinical trial eligibility criteria: eligible ages (years): 18.0-60.0,  Healthy Volunteers Overtly healthy individuals based on the history and physical examinations as determined by the investigator Are normotensive (defined as supine systolic blood pressure [BP] less than 140 millimeters of mercury [mm Hg] and diastolic BP less than 90 mm Hg without the use of any antihypertensives) or results that are judged to be not clinically significant by the investigator  Have presence of clinically significant active bleeding or history of bleeding diathesis at the time of screening Have presence of active peptic ulcer disease, gastro-intestinal (GI) bleeding, chronic gastritis, inflammatory bowel disease, or chronic diarrhea Have evidence of other chronic liver disease Have any use of nonsteroidal anti-inflammatory drugs (NSAIDs), celecoxib, aspirin, or acetaminophen (at doses greater than 1 gram per day [g/day] within 14 days of admission Have greater than 1 plus pretibial pitting edema or 2 plus ankle or pedal edema
Patient description: The patients is a 25-year-old G1 P1 pregnant woman who is 24W3D gestational old who developed a sudden unset of fever and chills, accompany with nausea and vomiting. She also complains of dysuria, urgency and frequency. She also reports some severe pain in the flank. Her vital signs are: T = 39.7ºC, P = 117, R = 20, and BP = 113/74 mm Hg. Physical examination reveals tenderness on palpation of both costovertebral angles. She has no history of recurrent UTI prior to her pregnancy or any other underlying disease. The urine culture showed Gram-negative rod-shaped bacterial cells, leukocytes, and leukocyte casts. The blood culture is negative. A CBC shows Hb 12.9 g/dL, Hct 39%, MCV 76 fL, WBC count 14,120/µL.

Clinical trial eligibility criteria: eligible ages (years): 18.0-999.0,  Post-ERCP Acute Pancreatitis one or more factors of >10% post-ERCP acute pancreatitis risk former episode of acute pancreatitis former episode of post-ERCP acute pancreatitis normal bilirubin level main pancreatic duct injection endoscopic biliary sphincteroplasty (balloon dilation of biliary sphincter) precut papillotomy pancreatic sphincterotomy  patient for whom a pancreatic stent is inserted (Sphincter of Oddi dysfunction, ampullectomy) ongoing acute pancreatitis chronic pancreatitis (Cremer classification >=2) age < 18 y/o pregnancy hemin allergy severe renal failure (MDRD<30ml/min/1.73m2)
Patient description: The patients is a 25-year-old G1 P1 pregnant woman who is 24W3D gestational old who developed a sudden unset of fever and chills, accompany with nausea and vomiting. She also complains of dysuria, urgency and frequency. She also reports some severe pain in the flank. Her vital signs are: T = 39.7ºC, P = 117, R = 20, and BP = 113/74 mm Hg. Physical examination reveals tenderness on palpation of both costovertebral angles. She has no history of recurrent UTI prior to her pregnancy or any other underlying disease. The urine culture showed Gram-negative rod-shaped bacterial cells, leukocytes, and leukocyte casts. The blood culture is negative. A CBC shows Hb 12.9 g/dL, Hct 39%, MCV 76 fL, WBC count 14,120/µL.

Clinical trial eligibility criteria: eligible ages (years): 18.0-75.0,  Postoperative Nausea and Vomiting Adult patients aged 18-75 years Scheduled for bariatric surgery under total intra-venous closed-loop anesthesia Apfel score equal or greater than 2 Consenting to participate in the study  Pregnant, breast feeding women Allergy Contraindication to dexamethasone Contraindication to ondansetron Contraindication to propofol, remifentanil, morphine, ketoprofen Limit to the use of bispectral index
Patient description: The patients is a 25-year-old G1 P1 pregnant woman who is 24W3D gestational old who developed a sudden unset of fever and chills, accompany with nausea and vomiting. She also complains of dysuria, urgency and frequency. She also reports some severe pain in the flank. Her vital signs are: T = 39.7ºC, P = 117, R = 20, and BP = 113/74 mm Hg. Physical examination reveals tenderness on palpation of both costovertebral angles. She has no history of recurrent UTI prior to her pregnancy or any other underlying disease. The urine culture showed Gram-negative rod-shaped bacterial cells, leukocytes, and leukocyte casts. The blood culture is negative. A CBC shows Hb 12.9 g/dL, Hct 39%, MCV 76 fL, WBC count 14,120/µL.

Clinical trial eligibility criteria: eligible ages (years): 18.0-999.0,  Peripheral Vertigo Presenting to emergency department with vertigo symptoms Adult patients (over 18) Agree to participate to study (understanding the study protocol and signing the informed consent form)  Patients under 18 years Patients diagnosed with ischemic/hemorrhagic stroke after neuroimaging Patient diagnosed with transient ischemic attack Pregnants Patients taking any analgesics or antihistaminic drugs last 24 hours Documented or declared allergy to dimenhydrinate, piracetam or benzodiazepines Patients who do not agree to participate to the study
Patient description: The patients is a 25-year-old G1 P1 pregnant woman who is 24W3D gestational old who developed a sudden unset of fever and chills, accompany with nausea and vomiting. She also complains of dysuria, urgency and frequency. She also reports some severe pain in the flank. Her vital signs are: T = 39.7ºC, P = 117, R = 20, and BP = 113/74 mm Hg. Physical examination reveals tenderness on palpation of both costovertebral angles. She has no history of recurrent UTI prior to her pregnancy or any other underlying disease. The urine culture showed Gram-negative rod-shaped bacterial cells, leukocytes, and leukocyte casts. The blood culture is negative. A CBC shows Hb 12.9 g/dL, Hct 39%, MCV 76 fL, WBC count 14,120/µL.

Clinical trial eligibility criteria: eligible ages (years): 18.0-38.0,  Embryo Culture <38 years (with own oocytes) / <45 years (with oocyte donation) First treatment with own oocytes / any treatment with oocyte donation ≥10 oocytes with a diameter of ≥10 mm  Diseases that affect endometrial receptivity: endometriosis, hydrosalpinx, ovarian hyperstimulation syndrome, obesity, endocrinopathies, thrombophilia, congenital or acquired uterine anomalies Patients under a treatment with genetic preimplantation diagnosis
Patient description: The patients is a 25-year-old G1 P1 pregnant woman who is 24W3D gestational old who developed a sudden unset of fever and chills, accompany with nausea and vomiting. She also complains of dysuria, urgency and frequency. She also reports some severe pain in the flank. Her vital signs are: T = 39.7ºC, P = 117, R = 20, and BP = 113/74 mm Hg. Physical examination reveals tenderness on palpation of both costovertebral angles. She has no history of recurrent UTI prior to her pregnancy or any other underlying disease. The urine culture showed Gram-negative rod-shaped bacterial cells, leukocytes, and leukocyte casts. The blood culture is negative. A CBC shows Hb 12.9 g/dL, Hct 39%, MCV 76 fL, WBC count 14,120/µL.

Clinical trial eligibility criteria: eligible ages (years): 18.0-999.0,  Sepsis Systemic Inflammatory Response Syndrome Infection Mixed Infection, Bacterial Infection, Fungal Infection, Coronavirus Adult patients with 3 of 4 systemic inflammatory response syndrome (SIRS) characteristics (1. tachycardia, 2. fever or hypothermia, 3. tachypnea, 4. leukocytosis), who have blood cultures drawn and urine collected for the evaluation of suspected sepsis, and/or other bodily fluids collected for culture and sensitivity analysis. Patients with other sources of infection with less than 3 of 4 SIRS  Pediatric patients
Patient description: The patients is a 25-year-old G1 P1 pregnant woman who is 24W3D gestational old who developed a sudden unset of fever and chills, accompany with nausea and vomiting. She also complains of dysuria, urgency and frequency. She also reports some severe pain in the flank. Her vital signs are: T = 39.7ºC, P = 117, R = 20, and BP = 113/74 mm Hg. Physical examination reveals tenderness on palpation of both costovertebral angles. She has no history of recurrent UTI prior to her pregnancy or any other underlying disease. The urine culture showed Gram-negative rod-shaped bacterial cells, leukocytes, and leukocyte casts. The blood culture is negative. A CBC shows Hb 12.9 g/dL, Hct 39%, MCV 76 fL, WBC count 14,120/µL.

Clinical trial eligibility criteria: eligible ages (years): 18.0-999.0,  Uncomplicated Urinary Tract Infection All adult patients presenting with a suspected urinary tract infection to their general practitioner (GP)
Patient description: The patients is a 25-year-old G1 P1 pregnant woman who is 24W3D gestational old who developed a sudden unset of fever and chills, accompany with nausea and vomiting. She also complains of dysuria, urgency and frequency. She also reports some severe pain in the flank. Her vital signs are: T = 39.7ºC, P = 117, R = 20, and BP = 113/74 mm Hg. Physical examination reveals tenderness on palpation of both costovertebral angles. She has no history of recurrent UTI prior to her pregnancy or any other underlying disease. The urine culture showed Gram-negative rod-shaped bacterial cells, leukocytes, and leukocyte casts. The blood culture is negative. A CBC shows Hb 12.9 g/dL, Hct 39%, MCV 76 fL, WBC count 14,120/µL.

Clinical trial eligibility criteria: eligible ages (years): 18.0-45.0,  Bulimia Nervosa Female Right-handed Age 18-45 Between 85 and 120% of ideal body weight based on height Currently meeting proposed DSM-5 for Bulimia Nervosa (at least one objective bulimic episode and compensatory purging episode per week for the past three months) Purging via self-induced vomiting Duration of illness of at least 6 months  Current significant medical illness Any disorder or condition resulting in difficulty swallowing (e.g., dysphagia) History of neurological disorders or diseases (e.g., stroke, seizures, heart disease, head trauma with loss of consciousness) Drug or alcohol abuse in the past 6 months or any history of alcohol or drug dependence Use of marijuana or any other illegal drug (e.g., cocaine, heroin, ecstasy) in the week before the study visit IQ less than 75 Pregnancy, lactation, or planning to become pregnant in the next year Allergy to sucrose, dairy, wheat, gluten, apples (i.e., any of the ingredients in the strawberry yogurt shake or in the standardized meal prior to study participation) Participants rating the strawberry yogurt shake as a 5 or lower on a 9-point category scale of liking will be excluded from further study Meeting the for a diagnosis of Attention Deficit Hyperactivity Disorder
Patient description: The patients is a 25-year-old G1 P1 pregnant woman who is 24W3D gestational old who developed a sudden unset of fever and chills, accompany with nausea and vomiting. She also complains of dysuria, urgency and frequency. She also reports some severe pain in the flank. Her vital signs are: T = 39.7ºC, P = 117, R = 20, and BP = 113/74 mm Hg. Physical examination reveals tenderness on palpation of both costovertebral angles. She has no history of recurrent UTI prior to her pregnancy or any other underlying disease. The urine culture showed Gram-negative rod-shaped bacterial cells, leukocytes, and leukocyte casts. The blood culture is negative. A CBC shows Hb 12.9 g/dL, Hct 39%, MCV 76 fL, WBC count 14,120/µL.

Clinical trial eligibility criteria: eligible ages (years): 18.0-100.0,  Recurrent Urinary Tract Infection Postmenopausal status as defined by amenorrhea for >12 months, OR history of bilateral salpingoophrectomy, OR if the patient has had a hysterectomy defined by menopausal symptoms for >1 year OR age >55 2. Documented recurrent UTIs (3 or more in the last year or 2 or more in the last 6 months) one UTI must be documented by culture, others may be documented by urinalysis 3. Ability to provide informed consent  Use of any investigational drug or device within thirty days of screening 2. Urologic surgery within the past 3 months of screening or plan for surgery within one year of screening 3. Diagnosis of Interstitial Cystitis/painful bladder syndrome 4. History of urinary tract infections which require the use of IV antibiotics or where only one oral antibiotic is available for treatment, or where the risk of treatment with vaginal estrogen only is deemed unacceptable by the principle investigator secondary to the severity of prior urinary tract infections 5. Known etiology of infection such as, but not limited to: kidney or bladder stones, enterovaginal/vesical fistula, fecal incontinence, intermittent catheterization, indwelling catheter, poorly controlled diabetes 6. Urothelial cancer 7. Actively treated estrogen sensitive tumor (breast or endometrial cancer) 8. Undiagnosed vaginal bleeding 9. Inability to use a vaginal ring (secondary to advanced prolapse or shortened vaginal length) 10. Any medical reason the investigator deems incompatible with treatment with vaginal estrogen 11. Prolapse requiring pessary use Deferral 1. Undiagnosed hematuria may enroll after malignancy is ruled out 2. Use of a progestin containing intrauterine device or use of any vaginal androgens, estrogens or progestins within 3 months of enrollment may enroll after wash out 3. Use of drugs/supplements known to prevent UTIs (ie cranberry products, prophylactic antibiotics, methenamine hippurate) 1 month prior to enrollment may enroll after wash out if still meets criteria. 4. History of estrogen sensitive tumor (breast or endometrial cancer) requires approval by the subject's primary oncologist or primary care physician
Patient description: The patients is a 25-year-old G1 P1 pregnant woman who is 24W3D gestational old who developed a sudden unset of fever and chills, accompany with nausea and vomiting. She also complains of dysuria, urgency and frequency. She also reports some severe pain in the flank. Her vital signs are: T = 39.7ºC, P = 117, R = 20, and BP = 113/74 mm Hg. Physical examination reveals tenderness on palpation of both costovertebral angles. She has no history of recurrent UTI prior to her pregnancy or any other underlying disease. The urine culture showed Gram-negative rod-shaped bacterial cells, leukocytes, and leukocyte casts. The blood culture is negative. A CBC shows Hb 12.9 g/dL, Hct 39%, MCV 76 fL, WBC count 14,120/µL.

Clinical trial eligibility criteria: eligible ages (years): 18.0-999.0,  Urinary Tract Infections Cystitis Female gender Age ≥ 18 years Written informed consent At least one of four key UTI symptoms that could be attributed to an uncomplicated UTI, and no alternative explanation (i.e. symptoms suggestive of STI or vulvo-vaginitis) Dysuria Urgency (including nocturia) Frequency Suprapubic tenderness Urine dipstick test positive for either nitrites or leukocyte esterase Patient is at increased risk for resistant pathogens, e.g., FQ-resistant or ESBL-producing Enterobacteriacae  Male sex Pregnancy or planned pregnancy Known carriage of nitrofurantoin or fosfomycin-resistant uropathogens(s) Concomitant antimicrobial therapy Use of any antibiotics in the past 7 days Known or suspected hypersensitivity or allergy to fosfomycin or nitrofurantoin History of lung or liver reaction or peripheral neuropathy after use of nitrofurantoin or other nitrofurans in the past Pre-existing polyneuropathy G6PD deficiency
Patient description: The patients is a 25-year-old G1 P1 pregnant woman who is 24W3D gestational old who developed a sudden unset of fever and chills, accompany with nausea and vomiting. She also complains of dysuria, urgency and frequency. She also reports some severe pain in the flank. Her vital signs are: T = 39.7ºC, P = 117, R = 20, and BP = 113/74 mm Hg. Physical examination reveals tenderness on palpation of both costovertebral angles. She has no history of recurrent UTI prior to her pregnancy or any other underlying disease. The urine culture showed Gram-negative rod-shaped bacterial cells, leukocytes, and leukocyte casts. The blood culture is negative. A CBC shows Hb 12.9 g/dL, Hct 39%, MCV 76 fL, WBC count 14,120/µL.

Clinical trial eligibility criteria: eligible ages (years): 18.0-65.0,  Viral Haemorrhagic Fever Dengue Fever Viral diseases, such as dengue fever, kidney of hemorrhagic fever, such as xinjiang hemorrhagic fever; Or clinical has fever associated with bleeding as the main performance, and confirmed as the new emergent infectious diseases  Diagnosed with flu, hand, foot and mouth disease, viral hepatitis (except the carrier), liver cirrhosis after hepatitis, AIDS, rabies, encephalitis, polio, measles, German measles, chickenpox, herpes, infectious mononucleosis, infectious atypical pneumonia
Patient description: The patients is a 25-year-old G1 P1 pregnant woman who is 24W3D gestational old who developed a sudden unset of fever and chills, accompany with nausea and vomiting. She also complains of dysuria, urgency and frequency. She also reports some severe pain in the flank. Her vital signs are: T = 39.7ºC, P = 117, R = 20, and BP = 113/74 mm Hg. Physical examination reveals tenderness on palpation of both costovertebral angles. She has no history of recurrent UTI prior to her pregnancy or any other underlying disease. The urine culture showed Gram-negative rod-shaped bacterial cells, leukocytes, and leukocyte casts. The blood culture is negative. A CBC shows Hb 12.9 g/dL, Hct 39%, MCV 76 fL, WBC count 14,120/µL.

Clinical trial eligibility criteria: eligible ages (years): 15.0-50.0,  Nausea Vomiting Markedly Reduced Food Intake Severe Dehydration 14 week pregnant women nausea protracted vomiting inability to tolerate food intake accompanied by obvious dehydration severe enough to justify hospitalisation at least 2+ ketonuria on dipstick urinanalysis  with metabolic disorders such as diabet, thyroid